These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 26757748

  • 1. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
    Delli K, Haacke EA, Kroese FG, Pollard RP, Ihrler S, van der Vegt B, Vissink A, Bootsma H, Spijkervet FK.
    Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
    [Abstract] [Full Text] [Related]

  • 2. Abatacept treatment of patients with primary Sjögren's syndrome results in a decrease of germinal centres in salivary gland tissue.
    Haacke EA, van der Vegt B, Meiners PM, Vissink A, Spijkervet FK, Bootsma H, Kroese FG.
    Clin Exp Rheumatol; 2017 Nov; 35(2):317-320. PubMed ID: 27908305
    [Abstract] [Full Text] [Related]

  • 3. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome.
    Pijpe J, Meijer JM, Bootsma H, van der Wal JE, Spijkervet FK, Kallenberg CG, Vissink A, Ihrler S.
    Arthritis Rheum; 2009 Nov; 60(11):3251-6. PubMed ID: 19877054
    [Abstract] [Full Text] [Related]

  • 4. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.
    Cornec D, Costa S, Devauchelle-Pensec V, Jousse-Joulin S, Marcorelles P, Berthelot JM, Chiche L, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Saraux A, Pers JO.
    J Autoimmun; 2016 Feb; 67():102-110. PubMed ID: 26688003
    [Abstract] [Full Text] [Related]

  • 5. Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy.
    Hamza N, Bootsma H, Yuvaraj S, Spijkervet FK, Haacke EA, Pollard RP, Visser A, Vissink A, Kallenberg CG, Kroese FG, Bos NA.
    Ann Rheum Dis; 2012 Nov; 71(11):1881-7. PubMed ID: 22615459
    [Abstract] [Full Text] [Related]

  • 6. FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients.
    Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, Kroese FGM.
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F, Cipriani P, Marrelli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R.
    Arthritis Res Ther; 2013 Oct 30; 15(5):R172. PubMed ID: 24286296
    [Abstract] [Full Text] [Related]

  • 8. Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study.
    Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Di Benedetto P, Cipriani P, Giacomelli R, Gerli R.
    Clin Exp Immunol; 2016 Jun 30; 184(3):284-92. PubMed ID: 26814615
    [Abstract] [Full Text] [Related]

  • 9. Brief Report: Ultrasonographic Assessment of Salivary Gland Response to Rituximab in Primary Sjögren's Syndrome.
    Jousse-Joulin S, Devauchelle-Pensec V, Cornec D, Marhadour T, Bressollette L, Gestin S, Pers JO, Nowak E, Saraux A.
    Arthritis Rheumatol; 2015 Jun 30; 67(6):1623-8. PubMed ID: 25708147
    [Abstract] [Full Text] [Related]

  • 10. B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.
    Verstappen GM, Kroese FG, Meiners PM, Corneth OB, Huitema MG, Haacke EA, van der Vegt B, Arends S, Vissink A, Bootsma H, Abdulahad WH.
    J Rheumatol; 2017 Jan 30; 44(1):49-58. PubMed ID: 28042126
    [Abstract] [Full Text] [Related]

  • 11. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
    Lisi S, Sisto M, D'Amore M, Lofrumento DD.
    Int Immunol; 2015 Apr 30; 27(4):183-94. PubMed ID: 25381666
    [Abstract] [Full Text] [Related]

  • 12. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome.
    Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, Bootsma H, Kallenberg CG, Spijkervet FK.
    Rheumatology (Oxford); 2007 Feb 30; 46(2):335-41. PubMed ID: 16891656
    [Abstract] [Full Text] [Related]

  • 13. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
    Meiners PM, Arends S, Brouwer E, Spijkervet FK, Vissink A, Bootsma H.
    Ann Rheum Dis; 2012 Aug 30; 71(8):1297-302. PubMed ID: 22258489
    [Abstract] [Full Text] [Related]

  • 14. Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
    Fisher BA, Everett CC, Rout J, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Carr A, Pease CT, Price EJ, Sutcliffe N, Makdissi J, Tappuni AR, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Richards A, Sharples LD, Bombardieri M, Bowman SJ.
    Ann Rheum Dis; 2018 Mar 30; 77(3):412-416. PubMed ID: 29275334
    [Abstract] [Full Text] [Related]

  • 15. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome.
    Mossel E, Delli K, van Nimwegen JF, Stel AJ, Kroese FGM, Spijkervet FKL, Vissink A, Arends S, Bootsma H, EULAR US-pSS Study Group.
    Ann Rheum Dis; 2017 Nov 30; 76(11):1883-1889. PubMed ID: 28754802
    [Abstract] [Full Text] [Related]

  • 16. Ig gene analysis reveals altered selective pressures on Ig-producing cells in parotid glands of primary Sjögren's syndrome patients.
    Hamza N, Hershberg U, Kallenberg CG, Vissink A, Spijkervet FK, Bootsma H, Kroese FG, Bos NA.
    J Immunol; 2015 Jan 15; 194(2):514-21. PubMed ID: 25488989
    [Abstract] [Full Text] [Related]

  • 17. Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.
    Haacke EA, van der Vegt B, Vissink A, Spijkervet FKL, Bootsma H, Kroese FGM.
    Ann Rheum Dis; 2017 Oct 15; 76(10):1781-1784. PubMed ID: 28710097
    [Abstract] [Full Text] [Related]

  • 18. Granulomatous interstitial nephritis associated with Primary Sjögren's syndrome.
    Bitik B, Gonul II, Haznedaroglu S, Goker B, Tufan A.
    Z Rheumatol; 2017 Jun 15; 76(5):458-460. PubMed ID: 28197771
    [Abstract] [Full Text] [Related]

  • 19. Clinical, histopathological and immunohistological study of lymphoid disorders in the parotid gland of patients with Sjögren's syndrome.
    Bozinović MT, Katić V, Krasić D, Veselinović D, Jovanović P, Krstić M.
    Vojnosanit Pregl; 2009 Dec 15; 66(12):955-60. PubMed ID: 20095514
    [Abstract] [Full Text] [Related]

  • 20. Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren's syndrome patients.
    van Ginkel MS, Haacke EA, Bootsma H, Arends S, van Nimwegen JF, Verstappen GM, Spijkervet FKL, Vissink A, van der Vegt B, Kroese FGM.
    Clin Exp Rheumatol; 2019 Dec 15; 37 Suppl 118(3):42-48. PubMed ID: 31074726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.